TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

SEATTLE, June 2, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that Dr. Steven Quay, M.D., Ph.D., President and Chief Executive Officer, will present…

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held at the Marriott Marquis,…

FORE Biotherapeutics to Present at Jefferies Global Healthcare Conference 2025

PHILADELPHIA, PA — FORE Biotherapeutics, a registration-stage biotherapeutics company, will participate in the Jefferies Global Healthcare Conference on Tuesday, June 3, 2025, in New York. CEO William Hinshaw and CFO Michael Byrnes will host and join one-on-one meetings. Contact your Jefferies representative or Argot Partners to schedule a meeting with the team.